2.88
Royalty Pharma plc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
2.55
FY23:
1.27
FY24:
1.80
FY25:
1.53
(positive)
Change from FY21 to FY25
billions USD
FY21:
14.6
FY22:
14.3
FY23:
15.1
FY24:
16.4
FY25:
18.1
Total assets
Change from FY21 to FY25
billions USD
FY21:
17.5
FY22:
16.8
FY23:
16.4
FY24:
18.2
FY25:
19.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
1.17
FY23:
0.16
FY24:
1.25
FY25:
0.64
(negative)
Change from FY21 to FY25
billions USD
FY21:
7.10
FY22:
6.12
FY23:
6.14
FY24:
6.63
FY25:
9.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.2
FY22:
9.53
FY23:
10.1
FY24:
10.3
FY25:
9.71
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
17.5
FY22:
16.8
FY23:
16.4
FY24:
18.2
FY25:
19.6
All amounts in billions USD